GlassScriptPhysician profile
Brittany T Fox
NPI 1598100232
$6,343.36
in general payments reported to CMS, 2019-2025
29 companies · $2,746 in 2025
The $2,746 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,055 · 2022: $978 · 2023: $499 · 2024: $1,065 · 2025: $2,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,267 · Travel and Lodging: $1,027 · Education: $15.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,267.35 |
| Travel and Lodging | $1,026.77 |
| Education | $15.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,888.08 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Boston Scientific Corporation | $854.38 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $617.68 | 2021-2025 | Relistor |
| Biotronik Nro, INC. | $548.34 | 2023-2025 | Prospera, Biotronik |
| Collegium Pharmaceutical, INC. | $481.04 | 2021-2025 | Xtampza, Belbuca, Nucynta |
| Forte Bio-Pharma LLC | $330.88 | 2021-2024 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $327.17 | 2021-2025 | Ztlido |
| Abbott Laboratories | $256.04 | 2021-2025 | Proclaim, Eterna |
| Abbvie INC. | $145.16 | 2024-2025 | |
| Nevro Corp. | $127.11 | 2021-2024 | Senza |
| Grt US Holding, INC. | $124.80 | 2022 | |
| Relievant Medsystems, INC. | $106.67 | 2022 | |
| Averitas Pharma INC. | $64.48 | 2023-2024 | Qutenza |
| Virtus Pharmaceuticals LLC | $51.78 | 2021 | |
| Saluda Medical Americas, INC. | $50.19 | 2024-2025 | Evoke |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $49.96 | 2021-2022 | |
| Vertos Medical, INC. | $49.47 | 2024 | Mild Device Kit |
| Amgen INC. | $46.55 | 2021 | |
| Trevena, INC. | $36.20 | 2021-2022 | |
| Radius Health, INC. | $29.35 | 2021 | |
| Depuy Synthes Sales INC. | $24.75 | 2021 | |
| Almatica Pharma LLC | $23.32 | 2021 | |
| Bioventus LLC | $21.07 | 2022 | |
| Tersera Therapeutics LLC | $20.88 | 2023 | Prialt |
| Stimwave Technologies Incorporated | $18.14 | 2022 | |
| Fidia Pharma USA INC. | $17.13 | 2025 | Hymovis, Triluron |
| Pfizer INC. | $14.03 | 2021 | |
| Redhill Biopharma INC. | $11.88 | 2022 | |
| Foundation Fusion Solutions, LLC | $6.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.